渗透
发表于 2025-3-25 05:13:21
Vascular Tumors of the Breast,example, there is a wide range of cutaneous hemangiomas, any of which could present in the skin of the breast, these entities will not be discussed in this chapter. The first half of the chapter will deal with benign vascular tumors, followed by a discussion of radiation and lymphedema-associated va
antedate
发表于 2025-3-25 09:09:31
http://reply.papertrans.cn/64/6311/631020/631020_22.png
极为愤怒
发表于 2025-3-25 14:11:13
Adipocytic Tumors,oft tissue. Mammary tumors with lipomatous or liposarcomatous differentiation are infrequent but can present diagnostic difficulty if the context of the fatty differentiation is not recognized. Several mammary spindle cell tumors may show adipocytic differentiation, including fibroepithelial tumors
顾客
发表于 2025-3-25 16:48:08
http://reply.papertrans.cn/64/6311/631020/631020_24.png
Gudgeon
发表于 2025-3-25 23:03:12
http://reply.papertrans.cn/64/6311/631020/631020_25.png
Root494
发表于 2025-3-26 03:21:52
Book 2021phasis is placed on a practical approach to the morphologic interpretation and useful ancillary tests while exploring the differential diagnoses in depth. Given the overall low incidence of mesenchymal lesions of the breast along with their mimics, surgical pathologists are not consistently exposed
Coordinate
发表于 2025-3-26 04:48:23
http://reply.papertrans.cn/64/6311/631020/631020_27.png
铁砧
发表于 2025-3-26 12:00:33
http://reply.papertrans.cn/64/6311/631020/631020_28.png
颠簸下上
发表于 2025-3-26 15:52:15
s.Written by experts in the fieldThis book utilizes a uniform approach to provide a framework for the diagnosis of mesenchymal tumors of the breast while highlighting their mimics. Emphasis is placed on a practical approach to the morphologic interpretation and useful ancillary tests while exploring
PARA
发表于 2025-3-26 19:48:05
Periductal Stromal Hyperplasia and Periductal Stromal Tumor,sal and postmenopausal women (range: 24–89-years-old). PDST represent <1% of breast malignancies. Previously thought to be a subcategory of phyllodes tumors, their status as a distinct entity remains unclear.